Cita APA

Badoux, X. C., Keating, M. J., Wen, S., Wierda, W. G., O'Brien, S. M., Faderl, S., . . . Ferrajoli, A. (2013). Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia. J Clin Oncol.

Chicago Style Citation

Badoux, Xavier C., Michael J. Keating, Sijin Wen, William G. Wierda, Susan M. O'Brien, Stefan Faderl, Rachel Sargent, Jan A. Burger, i Alessandra Ferrajoli. "Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia." J Clin Oncol 2013.

Cita MLA

Badoux, Xavier C., et al. "Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia." J Clin Oncol 2013.